Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: implications for the optimal frequency of MRD monitoring.

Saved in:
Bibliographic Details
Title: Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: implications for the optimal frequency of MRD monitoring.
Authors: Jamison, Trevor1,2 (AUTHOR), Jabbour, Elias2 (AUTHOR), Karrar, Omer2 (AUTHOR), Jain, Nitin2 (AUTHOR), Haddad, Fadi G.2 (AUTHOR), Kebriaei, Partow3 (AUTHOR), Khouri, Issa3 (AUTHOR), Popat, Uday3 (AUTHOR), Yang, Hui2 (AUTHOR), Kugler, Eitan3 (AUTHOR), Garris, Rebecca2 (AUTHOR), Garcia-Manero, Guillermo2 (AUTHOR), Kantarjian, Hagop2 (AUTHOR), Short, Nicholas J.2 (AUTHOR) nshort@mdanderson.org
Source: Leukemia & Lymphoma. May2026, p1-4. 4p. 1 Illustration.
Database: Academic Search Ultimate
Description
ISSN:10428194
DOI:10.1080/10428194.2026.2679593